Kayıkçıoglu, E. and Findos, E. (2022) “The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide: Prognostic immune nutritional index and prostate adenocancer”, The Injector, 1(3), pp. 106–114. doi: 10.5281/zenodo.7331456.